The Medicine for Children Research Network’s (MCRN) Rheumatology CSG has invited Olivia’s Vision to participate in the forthcoming trial of Adalimumab (Humira) in children with JIA associated uveitis.
Our role is one of support for parents whose children will be involved in the trial, as well as advocate for those parents who would like their child to be considered for inclusion.
We will also be providing all carers and children with clear information, and will be able to answer questions and discuss any concerns that arise.
More details to follow.
